
zzso necrosis factor zzso have an established role in the treatment of inflammatory zzso diseases zzso however, zzso drug levels and the formation of zzso zzso zzso may decrease their zzso 

The evidence supporting the use of therapeutic drug monitoring zzso based clinical zzso for zzso zzso and their role in clinical practice will be zzso 

The literature was reviewed to identify relevant articles on the measurement of zzso levels and zzso 

Treatment zzso for zzso have evolved from episodic zzso used in patients zzso to all other treatments, to long-term combination therapy initiated early in the disease zzso zzso zzso rates have been observed with this paradigm shift, nevertheless many patients ultimately lose response to zzso Although zzso dose zzso or switching agents constitute the current standard of care for secondary failure, these interventions have not been applied in an evidence-based manner and are probably not zzso Multiple zzso zzso have been developed to identify patients that may benefit from measurement of zzso and zzso levels to guide adjustments to zzso 

zzso drug monitoring offers a rational approach to the management of secondary failure to zzso This concept has gained momentum based on evidence from case series, cohort studies and zzso analyses of zzso controlled zzso 

